IBDEI36R ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50866,1,3,0)
 ;;=3^Family Hx of Malig Neop of Testis
 ;;^UTILITY(U,$J,358.3,50866,1,4,0)
 ;;=4^Z80.43
 ;;^UTILITY(U,$J,358.3,50866,2)
 ;;=^5063350
 ;;^UTILITY(U,$J,358.3,50867,0)
 ;;=Z80.6^^193^2498^25
 ;;^UTILITY(U,$J,358.3,50867,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50867,1,3,0)
 ;;=3^Family Hx of Leukemia
 ;;^UTILITY(U,$J,358.3,50867,1,4,0)
 ;;=4^Z80.6
 ;;^UTILITY(U,$J,358.3,50867,2)
 ;;=^5063354
 ;;^UTILITY(U,$J,358.3,50868,0)
 ;;=Z80.8^^193^2498^30
 ;;^UTILITY(U,$J,358.3,50868,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50868,1,3,0)
 ;;=3^Family Hx of Malig Neop of Organs/Systems
 ;;^UTILITY(U,$J,358.3,50868,1,4,0)
 ;;=4^Z80.8
 ;;^UTILITY(U,$J,358.3,50868,2)
 ;;=^5063356
 ;;^UTILITY(U,$J,358.3,50869,0)
 ;;=Z81.8^^193^2498^35
 ;;^UTILITY(U,$J,358.3,50869,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50869,1,3,0)
 ;;=3^Family Hx of Mental/Behavioral Disorders
 ;;^UTILITY(U,$J,358.3,50869,1,4,0)
 ;;=4^Z81.8
 ;;^UTILITY(U,$J,358.3,50869,2)
 ;;=^5063363
 ;;^UTILITY(U,$J,358.3,50870,0)
 ;;=Z82.3^^193^2498^42
 ;;^UTILITY(U,$J,358.3,50870,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50870,1,3,0)
 ;;=3^Family Hx of Stroke
 ;;^UTILITY(U,$J,358.3,50870,1,4,0)
 ;;=4^Z82.3
 ;;^UTILITY(U,$J,358.3,50870,2)
 ;;=^5063367
 ;;^UTILITY(U,$J,358.3,50871,0)
 ;;=Z82.49^^193^2498^24
 ;;^UTILITY(U,$J,358.3,50871,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50871,1,3,0)
 ;;=3^Family Hx of Ischemic Heart Disease/Circulatory System
 ;;^UTILITY(U,$J,358.3,50871,1,4,0)
 ;;=4^Z82.49
 ;;^UTILITY(U,$J,358.3,50871,2)
 ;;=^5063369
 ;;^UTILITY(U,$J,358.3,50872,0)
 ;;=Z82.5^^193^2498^14
 ;;^UTILITY(U,$J,358.3,50872,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50872,1,3,0)
 ;;=3^Family Hx of Asthma/Chronic Lower Respiratory Diseases
 ;;^UTILITY(U,$J,358.3,50872,1,4,0)
 ;;=4^Z82.5
 ;;^UTILITY(U,$J,358.3,50872,2)
 ;;=^5063370
 ;;^UTILITY(U,$J,358.3,50873,0)
 ;;=Z82.61^^193^2498^13
 ;;^UTILITY(U,$J,358.3,50873,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50873,1,3,0)
 ;;=3^Family Hx of Arthritis
 ;;^UTILITY(U,$J,358.3,50873,1,4,0)
 ;;=4^Z82.61
 ;;^UTILITY(U,$J,358.3,50873,2)
 ;;=^5063371
 ;;^UTILITY(U,$J,358.3,50874,0)
 ;;=Z82.69^^193^2498^37
 ;;^UTILITY(U,$J,358.3,50874,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50874,1,3,0)
 ;;=3^Family Hx of Musculoskeletal System/Connective Tissue
 ;;^UTILITY(U,$J,358.3,50874,1,4,0)
 ;;=4^Z82.69
 ;;^UTILITY(U,$J,358.3,50874,2)
 ;;=^5063373
 ;;^UTILITY(U,$J,358.3,50875,0)
 ;;=Z83.3^^193^2498^20
 ;;^UTILITY(U,$J,358.3,50875,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50875,1,3,0)
 ;;=3^Family Hx of Diabetes Mellitus
 ;;^UTILITY(U,$J,358.3,50875,1,4,0)
 ;;=4^Z83.3
 ;;^UTILITY(U,$J,358.3,50875,2)
 ;;=^5063379
 ;;^UTILITY(U,$J,358.3,50876,0)
 ;;=Z83.2^^193^2498^16
 ;;^UTILITY(U,$J,358.3,50876,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50876,1,3,0)
 ;;=3^Family Hx of Blood/Immune Mechanism Diseases
 ;;^UTILITY(U,$J,358.3,50876,1,4,0)
 ;;=4^Z83.2
 ;;^UTILITY(U,$J,358.3,50876,2)
 ;;=^5063378
 ;;^UTILITY(U,$J,358.3,50877,0)
 ;;=Z82.71^^193^2498^40
 ;;^UTILITY(U,$J,358.3,50877,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50877,1,3,0)
 ;;=3^Family Hx of Polycystic Kidney
 ;;^UTILITY(U,$J,358.3,50877,1,4,0)
 ;;=4^Z82.71
 ;;^UTILITY(U,$J,358.3,50877,2)
 ;;=^321531
 ;;^UTILITY(U,$J,358.3,50878,0)
 ;;=Z82.1^^193^2498^15
 ;;^UTILITY(U,$J,358.3,50878,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50878,1,3,0)
 ;;=3^Family Hx of Blindness/Visual Loss
